Local Anesthetic

RegulatoryJune 9, 2026

FDA Approval Status Update for Lidocaine Hydrochloride 0.4% in Dextrose 5%

The FDA has granted an approval status (AP) for ANDA083158, a supplemental application for Lidocaine Hydrochloride 0.4% in Dextrose 5% submitted by Hospira.

Companies

Assets

Recent signals(5)

FDA Grants Approval for Bupivacaine Hydrochloride by Anthea Pharma

Anthea Pharma's Bupivacaine Hydrochloride ANDA220493 Receives AP Status

FDA Grants AP Status for Lidocaine Hydrochloride ANDA040078

FDA Grants AP Status for Lidocaine Hydrochloride 0.4% in Dextrose 5%

FDA Approval Status Update for Lidocaine Hydrochloride 0.4% in Dextrose 5%

Upcoming catalysts

Indications

Get signals before the market moves